Danko Martincic
YOU?
Author Swipe
View article: 665 JAVELIN Bladder Medley: a phase 2 trial of avelumab in combination with other antitumor drugs as first-line maintenance therapy for advanced urothelial carcinoma
665 JAVELIN Bladder Medley: a phase 2 trial of avelumab in combination with other antitumor drugs as first-line maintenance therapy for advanced urothelial carcinoma Open
Background In the JAVELIN Bladder 100 trial (NCT02603432), avelumab (anti–PD-L1) first-line (1L) maintenance + best supportive care (BSC) significantly prolonged overall survival (OS) and progression-free survival (PFS) vs BSC alone in pat…
View article: <i>TG-Interacting Factor 1</i> expression quantitatively impacts survival in acute myeloid leukemia
<i>TG-Interacting Factor 1</i> expression quantitatively impacts survival in acute myeloid leukemia Open
Applying transcriptional profiling analysis to myeloblasts from 59 adult patients with acute myeloid leukemia (AML) treated at our institution, we found that expression of the three-amino acid loop extension (TALE) homeobox gene TG-Interac…